Page last updated: 2024-10-29

indapamide and Obesity

indapamide has been researched along with Obesity in 11 studies

Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research Excerpts

ExcerptRelevanceReference
"To assess real-life effectiveness of a perindopril/indapamide (Per/Ind) single-pill combination (SPC) in patients with hypertension (HT) and type 2 diabetes mellitus (T2DM), obesity and/or metabolic syndrome (MetS)."9.12Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational Studies. ( Brzozowska-Villatte, R; De Champvallins, M; Dézsi, CA; Farsang, C; Glezer, M; Karpov, Y, 2021)
"To assess real-life effectiveness of a perindopril/indapamide (Per/Ind) single-pill combination (SPC) in patients with hypertension (HT) and type 2 diabetes mellitus (T2DM), obesity and/or metabolic syndrome (MetS)."5.12Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational Studies. ( Brzozowska-Villatte, R; De Champvallins, M; Dézsi, CA; Farsang, C; Glezer, M; Karpov, Y, 2021)
"To study the effectiveness of a fixed combination of perindopril and amlodipine, with the subsequent addition of indapamide-retard in male patients with arterial hypertension (AH), obesity and severe sleep apnea (OSAS)."3.88The effectiveness of combination antihypertensive therapy in patients with arterial hypertension and additional risk factors: obesity and obstructive sleep apnea syndrome. ( Chazova, IE; Elfimova, EM; Litvin, AY, 2018)
" We thus investigated the long-term effects of an angiotensin-converting enzyme (ACE) inhibitor (perindopril)/diuretic (indapamide) combination (per/ind) in the Zucker rat, a classical model of chronic renal failure associated with obesity, hyperlipidemia, and insulin resistance."3.72Long-term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angiotensin-converting enzyme inhibitor/diuretic combination. ( Belair, MF; Chainey, A; Chevalier, J; Mandet, C; Michel, O; Myara, I; Plante, GE; Renaud, IM, 2004)
"Weight loss is strongly recommended for overweight and obese adults with type 2 diabetes."2.94The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE. ( Chalmers, J; Hamet, P; Harrap, S; Lee, AK; Marre, M; Mcevoy, JW; Ohkuma, T; Selvin, E; Sharrett, AR; Wang, D; Warren, B; Williams, B; Woodward, M, 2020)
"Telmisartan was more effective, whereas indapamide had better pharmacoeconomic benefits."2.80Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure. ( Liu, Z; Lu, F; Peng, J; Tang, M; Wang, Z; Zhang, H; Zhang, W; Zhao, Y; Zhong, M, 2015)
" All groups had mean diastolic pressure controlled at or below the 90 mmHg criterion during the period of constant methyldopa dosage for those patients who required Step 2 therapy."2.65Indapamide in the stepped-care treatment of obese hypertensive patients. ( Godfrey, JC; Neiss, ES; Noble, RE; Vukovich, RA; Webb, EL; Zisblatt, M, 1983)
"Treatment with amlodipine, candesartan, or indapamide did not significantly affect plasma visfatin levels."1.43Effects of antihypertensive treatment on plasma apelin, resistin, and visfatin concentrations. ( Piecha, G; Skoczylas, A; Więcek, A, 2016)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's4 (36.36)24.3611
2020's3 (27.27)2.80

Authors

AuthorsStudies
Lee, AK1
Woodward, M2
Wang, D1
Ohkuma, T1
Warren, B1
Sharrett, AR1
Williams, B2
Marre, M2
Hamet, P1
Harrap, S1
Mcevoy, JW1
Chalmers, J2
Selvin, E1
Farsang, C1
Dézsi, CA1
Brzozowska-Villatte, R1
De Champvallins, M1
Glezer, M1
Karpov, Y1
Rosolová, H1
Mohammedi, K1
Herrington, W1
Li, Q1
Mancia, G1
Poulter, N1
Rodgers, A1
Perkovic, V1
Coresh, J1
Elfimova, EM1
Litvin, AY1
Chazova, IE1
Peng, J1
Zhao, Y1
Zhang, H1
Liu, Z1
Wang, Z1
Tang, M1
Zhong, M1
Lu, F1
Zhang, W1
Skoczylas, A1
Piecha, G1
Więcek, A1
Kaplan, NM1
Toblli, JE1
DeRosa, G1
Rivas, C1
Cao, G1
Piorno, P1
Pagano, P1
Forcada, P1
Renaud, IM1
Chainey, A1
Belair, MF1
Mandet, C1
Michel, O1
Myara, I1
Chevalier, J1
Plante, GE1
Noble, RE1
Webb, EL1
Godfrey, JC1
Zisblatt, M1
Vukovich, RA1
Neiss, ES1

Reviews

1 review available for indapamide and Obesity

ArticleYear
Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational Studies.
    Advances in therapy, 2021, Volume: 38, Issue:4

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Humans;

2021

Trials

4 trials available for indapamide and Obesity

ArticleYear
The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.
    The Journal of clinical endocrinology and metabolism, 2020, 01-01, Volume: 105, Issue:1

    Topics: Adult; Aged; Body-Weight Trajectory; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Combin

2020
Associations between body mass index and the risk of renal events in patients with type 2 diabetes.
    Nutrition & diabetes, 2018, 01-17, Volume: 8, Issue:1

    Topics: Aged; Albuminuria; Blood Glucose; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Drug Combi

2018
Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2015, Volume: 38, Issue:2

    Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; China; Double-Blind Method

2015
Indapamide in the stepped-care treatment of obese hypertensive patients.
    Current medical research and opinion, 1983, Volume: 8 Suppl 3

    Topics: Adult; Aged; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans;

1983

Other Studies

6 other studies available for indapamide and Obesity

ArticleYear
How to treat arterial hypertension in obese patients?
    Vnitrni lekarstvi, 2020,Winter, Volume: 66, Issue:8

    Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diuretics; Humans; Hypertension; Indapamide; Obe

2020
The effectiveness of combination antihypertensive therapy in patients with arterial hypertension and additional risk factors: obesity and obstructive sleep apnea syndrome.
    Terapevticheskii arkhiv, 2018, Dec-30, Volume: 90, Issue:12

    Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; H

2018
Effects of antihypertensive treatment on plasma apelin, resistin, and visfatin concentrations.
    Polskie Archiwum Medycyny Wewnetrznej, 2016, Apr-29, Volume: 126, Issue:4

    Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers;

2016
[The challenge to treat hypertensive patients with type 2 diabetes].
    Presse medicale (Paris, France : 1983), 2002, Volume: 31 Spec No 2

    Topics: Adult; Albuminuria; Antihypertensive Agents; Body Mass Index; Cardiovascular Diseases; Diabetes Mell

2002
Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats.
    Journal of hypertension, 2003, Volume: 21, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiova

2003
Long-term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angiotensin-converting enzyme inhibitor/diuretic combination.
    Fundamental & clinical pharmacology, 2004, Volume: 18, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diuretics; Drug Combinations; Fibrosis; Indapamid

2004